Prevention of cardiac dysfunction, kidney fibrosis and lipid metabolic alterations in l-NAME hypertensive rats by sinapic acid—Role of HMG-CoA reductase.

MLA

Silambarasan, Thangarasu, et al. “Prevention of Cardiac Dysfunction, Kidney Fibrosis and Lipid Metabolic Alterations in l-NAME Hypertensive Rats by Sinapic Acid—Role of HMG-CoA Reductase.” European Journal of Pharmacology, vol. 777, Apr. 2016, pp. 113–23. EBSCOhost, https://doi.org/10.1016/j.ejphar.2016.03.004.

APA

Silambarasan, T., Manivannan, J., Raja, B., & Chatterjee, S. (2016). Prevention of cardiac dysfunction, kidney fibrosis and lipid metabolic alterations in l-NAME hypertensive rats by sinapic acid—Role of HMG-CoA reductase. European Journal of Pharmacology, 777, 113–123. https://doi.org/10.1016/j.ejphar.2016.03.004

Chicago

Silambarasan, Thangarasu, Jeganathan Manivannan, Boobalan Raja, and Suvro Chatterjee. 2016. “Prevention of Cardiac Dysfunction, Kidney Fibrosis and Lipid Metabolic Alterations in l-NAME Hypertensive Rats by Sinapic Acid—Role of HMG-CoA Reductase.” European Journal of Pharmacology 777 (April): 113–23. doi:10.1016/j.ejphar.2016.03.004.